Home › NDC Lookup › RxCUI directory › RxCUI 984105

Sodium phenylbutyrate 0.94 MG/MG Oral Powder — RxCUI 984105

RxNorm drug concept · Semantic clinical drug
RxCUI 984105 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI984105
Official nameSodium phenylbutyrate 0.94 MG/MG Oral Powder
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium phenylbutyrate 0.94 GM/GM Oral Powder
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)137 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Sodium phenylbutyrate 0.94 MG/MG Oral Powder Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sodium phenylbutyrate 0.94 MG/MG Oral Powder RxCUI 984105

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Phenylbutyrate 81647
    • Sodium phenylbutyrate 214837
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Buphenyl 215778
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Phenylbutyrate Oral Powder 749750
    • Sodium phenylbutyrate Oral Powder 2646701
    • Phenylbutyrate Oral Powder Product 1295129
    • Phenylbutyrate Oral Product 1162577
    • Sodium phenylbutyrate Oral Powder Product 2662497
    • Sodium phenylbutyrate Oral Product 2659126
    • Phenylbutyrate Oral Powder [Buphenyl] 749753
    • Sodium phenylbutyrate Oral Powder [Buphenyl] 2658661
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sodium phenylbutyrate 0.94 MG/MG SCDC · 393421
  • Phenylbutyrate Oral Powder SCDF · 749750
  • Sodium phenylbutyrate Oral Powder SCDFP · 2646701
  • Phenylbutyrate Oral Powder Product SCDG · 1295129
  • Phenylbutyrate Oral Product SCDG · 1162577
  • Sodium phenylbutyrate Oral Powder Product SCDGP · 2662497
  • Sodium phenylbutyrate Oral Product SCDGP · 2659126

Brand-Name Concepts

  • Sodium phenylbutyrate 0.94 MG/MG Oral Powder [Buphenyl] SBD · 984107
  • Sodium phenylbutyrate 0.94 MG/MG [Buphenyl] SBDC · 984106
  • Phenylbutyrate Oral Powder [Buphenyl] SBDF · 749753
  • Sodium phenylbutyrate Oral Powder [Buphenyl] SBDFP · 2658661
  • Buphenyl Oral Powder Product SBDG · 1297025
  • Buphenyl Oral Product SBDG · 1168685
  • Buphenyl BN · 215778

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 984105 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49884-0006-04 1 BOTTLE in 1 CARTON (49884-006-04) / 250 g in 1 BOTTLE Sodium Phenylbutyrate Par Health USA, LLC 2016-08-31
75987-0060-08 1 BOTTLE in 1 CARTON (75987-060-08) / 250 TABLET in 1 BOTTL... BUPHENYL Horizon Therapeutics USA, Inc. 1996-05-13
75987-0070-09 1 BOTTLE in 1 CARTON (75987-070-09) / 250 g in 1 BOTTLE Buphenyl Horizon Therapeutics USA, Inc. 1996-04-30
Observed labelers: Horizon Therapeutics USA, Inc. (2) · Par Health USA, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.